IFITM3 variants point to a critical role in emergent virus infections
mBio · 2025
DOI: 10.1128/mbio.03347-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, 2025. Verfasst von Parker J Denz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Membrane Proteins, Virus Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Interferon-induced transmembrane protein 3 (IFITM3) is a cellular protein that restricts numerous viral infections by blocking virus–host membrane fusion. In humans, there are two IFITM3 single nucleotide polymorphisms (SNPs), rs12252-C and rs34481144-A, that decrease IFITM3 activity and have been associated with severe illness following influenza virus infections. Mice lacking IFITM3 show increased influenza severity, supporting this association. However, some studies do not find a consistent link between IFITM3 SNPs and infection severity, causing uncertainty about its role in vivo . Review of the literature indicates that IFITM3 SNPs are primarily associated with increased viral disease in infections with emergent influenza viruses, such as the 2009 H1N1 pandemic virus and zoonotic H7N9 virus. Similarly, IFITM3 SNPs are reported to be risk factors for increased severity in other emergent infections, including SARS-CoV-2, Hantaan virus, and HIV. In contrast, most studies that failed to find an association examined seasonal influenza. We posit that adaptive immune mechanisms, including pre-existing antibodies and memory T cells against seasonally circulating viruses, compensate for IFITM3 deficiencies, therefore masking its role in seasonal influenza. We propose that IFITM3 is most critical in defending against emergent viruses and should be a key focus of public health strategies to prevent the emergence and spread of novel pathogens, with individuals carrying IFITM3 SNPs potentially benefiting from broadened vaccine coverage, avoidance of animal reservoirs, or enhanced masking to protect themselves and the wider population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Infection and Immunity, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Parker J Denz, Jacob S Yount
Förderung
- NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Denz, P. J., & Yount, J. S. (2025). IFITM3 variants point to a critical role in emergent virus infections. mBio. https://doi.org/10.1128/mbio.03347-24
Vancouver
Denz PJ, Yount JS. IFITM3 variants point to a critical role in emergent virus infections. mBio. 2025. doi:10.1128/mbio.03347-24
BibTeX
@article{Denz2025,
author = {Denz, Parker J and Yount, Jacob S},
title = {IFITM3 variants point to a critical role in emergent virus infections},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.03347-24}
}
EUVIMED